APPLICATIONS PUBLISHED 16 JULY 2003
Published: 1-Jan-2004
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
The following patent applications are taken from the weekly European Patents Bulletin and give the publication number and date of publication as well as the title of the specification and the applicant. An asterisk denotes that application was made through the International Patent Cooperation Treaty (PCT). Further details on individual patent applications can be obtained from the EPO at Schottenfeldgasse 29, A-1072 Vienna. Tel: +43 1521 260 Fax: +43 1 52126 4492
Novel use of short-chained carboxylic acids
Henkel 1326577*
Oxidation colorants comprising 2-chloro-P-aminophenol
Henkel 1326578*
Medication delivery devices
3M Innovative Properties 1326583*
Delivery system and method of treating otitis media
Auris 1326584*
Method for producing powdery formulations
Boehringer Ingelheim 1326585*
New pharmaceutical compsns containing epinastine and pseudoephedrine
Boehringer Ingelheim 1326586*
Hydrogel-driven drug dosage form
Pfizer 1326587*
Oral dosage forms of Boswellia extracts
RP Scherer 1326588*
Nanoparticles
Consejo Superior de Investigaciones Cientificas 1326589*
Patch comprising diclofenac
Laboratoires Fournier 1326590*
Combinations of statins and sorbitol dehydrogenase inhibitors
Pfizer 1326591*
Use of polyethylene glycol (PEG) for the manufacture of a medicament for the treatment of constipation
Braintree Laboratories 1326592*
Oestrogen receptor-beta ligands
AstraZeneca 1326593*
Ribavarin-pegylated interferon alpha HCV combination therapy
Schering 1326594*
Pharmaceutical compsns comprising resveratrol for treating inflammatory respiratory disorders
Imperial College Innovations 1326596*
Pharmaceutical preparations containing a dibenzocycloocatne lignan derivative for prevention and treatment of neurodegenerative diseases
Elcom Bio Technology 1326596*
Methods for modulating bladder function
American Home Products 1326597*
Method for producing an extract from cannabis plant matter, containing a tetrahydrocannabinol and a cannabidiol and cannabis extracts
Delta-9-Pharma 1326598*
Treatment and prophylaxis of diseases and infections of pigs and poultry with aivolsin
Eco Animal Health 1326599*
Mediators of hedgehog signaling pathways, compsns and uses related thereto
Curis 1326600*
Use of melatonin for induction of general anaesthesia
University of Iowa Research Foundation 1326601*
Indole compounds as minimally physiologial function monitoring agents
Mallinckrodt 1326602*
Compsn comprising a catalyst for the dismutation of superoxide and use of the compsn for preventing and treating hypotension
Pharmacia 1326603*
Combination of at least two compounds selected from an AT1-receptor antagonist or an ACE inhibitor or a HMG-CoA reductase inhibitor groups
Novartis 1326604*
Methods for inhibiting proliferation and inducing apoptosis in cancer cells
Creighton University 1326605*
EP4 receptor inhibitors to treat rheumatoid arthritis
Pfizer Pharmaceuticals 1326606*
Pharmaceutical compsns containing oxapenem-3-carboxylic acids
Amura 1326607*
Stable compsns of oxapenem-3-carboxylic acids by co-lyophilisation with pharmaceutical carriers
Amura 1326608*
Stable oral formulation containing benzimidazole derivative
Galaphar 1326609*
Aza- and polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
Merck 1326610*
Aza- abd polyaza-naphthalenyl-carboxamides useful as HIV integrase inhibitors
Merck 1326611*
Gatifloxacin pentahydrate
Bristol-Myers Squibb 1326612*
Use of substituted imidazo 1,2-A]pyridine-, imidazo 1,2-A]pyrimidine and imidazo 1,2-A]pyrazine-3-yl-amine derivatives for producing nos-inhibiting medicaments
Grunenthal 1326613*
Tricyclic antidepressants and their analogues as long-acting local anaesthetics and analgesics
Brigham and Women's Hospital 1326614*
Phosphoric acid salt of an integrin receptor antagonist
Merck 1326615*
New use of quetiapine
AstraZeneca 1326616*
Use of antiprogestins for the induction of apoptosis in a cell
Schering 1326617*
Use of aryl-substituted 1,1-diphosphonates for the treatment of bone diseases
Ilex Oncology Research 1326618*
Pyrrolidine modulators of CCRS chemokine receptor activity
Merck 1326619*
S-adenosylmethionine and derivatives for the treatment and prevention of Alzheimer's disease
Universita' degli Studi di Roma 'La Sapienza' 1326620*
Medicinal compsn and in particular its use in fluid therapy
Universite de Liege 1326621*
Compsns and methods for treatment or multiple myeloma
Scheinbart, Eric 1326622*
Saururus chinesis extract for prevention and treatment of neurodegenerative disease
Elcom Bio Technology 1326623*
Method for producing Phyllanthus extracts
CMI-Centers for Medical Innovation 1326624*
Immunogebic compsn of hepatitis C and methods of use thereof
Hawaii Biotechnology Group 1326625*
Methods for treating rheumatoid arthritis using IL-17 antagonists
Immunex 1326626*
Methods of modulating apoptosis by administration of relaxin agonists or antagonists
Molecular Medicine Research Institute 1326627*
Chemokine mutants in the treatment of multiple sclerosis
Applied Research Systems ARS Holding 1326628*
Methods and compsns for promoting the maturation of monocytes
Maxim Pharmaceuticals 1326629*
Use of GLP-1 and GLP-2 peptides
Osteometer BioTech 1326630*
Methods for treating endocrine disorder
Allergan 1326631*
Agents for the treatment of viral infections
Viromics 1326632*
Compsn comprising immunogenic microparticles
The Austin Research Institute 1326633*
Vaccine compsn comprising an antigen and a peptide having adjuvant properties
Intercell Biomedizinsche Forschungs- und Entwicklungs 1326634*
Pharmaceutical compsn for immunisation against AIDS
Aventis Pasteur 1326635*
Vaccine compsn
Aventis Pasteur 1326636*
Vaccine comprising heat stress proteins from herbaceous plants
Jaliashvill, Tengiz A 1326637*
Vaccines
GlaxoSmithKline Biologicals 1326638*
Adjuvant compsn comprising an immunostimulatory oligonucleotide and a tocol
GlaxoSmithKline Biologicals 1326639*
Non-nuleoside reverse transcriptase inhibitor as antiretroviral therapy
Virologic 1326640*
System and methods for optimised drug delivery and progression of diseased and normal cells
Optimata 1326641*
Catecholamine pharmaceutical compsns and methods
Board of Trustees operating Michigan State University 1326642*
Inhibition of emetic effect of metformin with 5-HT3 receptor antagonists
DepoMed 1326643*
Absorption enhancers
Proxima Concepts 1326644*
Complexes for transferring nucleic acids into cells
Bayer 1326645*
Transferrin-polycation/DNA complexes for the systemic treatment of tumour diseases using cytotoxic proteins
Boehringer Ingelheim International 1326646*
Light sensitive compounds for instant determination of organ function
Mallinckrodt 1326647*
Novel dyes for organ function monitoring
Mallinckrodt 1326648*
Tissue-specific exogenous optical agents
Mallinckrodt 1326649*
Hydrophilic light absorbing compounds for determination of physiological function in critically ill patients
Mallinckrodt 1326650*
